生技月眾星雲集,連結國際創商機

2017年台灣生技月,將於6月28日至7月2日於台北南港展覽館舉行,主辦單位今年特別邀請多位全球重量級生技產業家出席,包含華生藥廠(Watson)創辦人趙宇天、賽默飛(Thermo Fisher Scientific)前診斷事業群總裁蔡裕庚、IMPAX創辦人許中強、NGM創辦人陳金龍、波士頓創業家盧冠達等,分享全球生技未來趨勢及營運策略。

Read more

OBI Pharma announces acquisition of cancer drug candidate from Threshold Pharmaceuticals

Taipei, Taiwan-headquartered OBI Pharma, Inc., (TPex: 4174), announced last week that an agreement with Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) had been made to acquire TH-3424, a first-in-class novel small-molecule prodrug that selectively targets cancers overexpressing the enzyme aldo-keto reductase 1c3 (AKR1C3).

Read more

Taiwan can become a regional biotech hub, says Vice President Chen

At a recent forum on enhancing the competitiveness of Taiwan’s biotechnology, health and wellness industries held in Taichung, central Taiwan, the country’s Vice President Chen Chien-jen said Taiwan can become a biotechnology hub for the Asia-Pacific region if proper efforts are made.

Read more